Kineticos’ Industry News is intended to provide life science executives with easy access to the most relevant and groundbreaking local (Research Triangle Park, NC), national and global news.
Week of January 2, 2016
- Sharp Packaging Transitions to CRĒDO Packaging Solution
- AstraZeneca opens UK Zoladex plant
- Vaccine ‘nanodiscs’ could personalize cancer immunotherapy
- Editor’s Corner: Signs point to a surprising pharma new year
- Humacyte launches Phase 2 trial of artificial blood vessel
Week of December 19, 2016
- Biogen names chief commercial officer as new CEO
- PPD increases capacity, capability at Wisconsin based GMP lab
- RTP key to more U.S. business, says U.K.-based MedPharm CEO
- How camels and llamas are inspiring new treatments for cancer, MS and more
- INC Research to move HQ from Raleigh to Morrisville, create 550 jobs
Week of December 5, 2016
- Pricing, access to drive debate as new meds push 2021 drug spending to $1.5T
- UNC Rex revenue headed for $1B, execs say
- Voluntis Receives FDA Clearance And CE Mark For Insulia A First For Digital Applications Supporting Type 2 Diabetes Patients Treated With Basal Insulin
- NeuroCog Trials CEO says company expanding in Durham
- Sanofi weighs Actelion offer to compete with J&J’s $27B: Bloomberg
Week of November 28, 2016
- NIH, others launch ‘historic’ HIV trial with vaccines from GSK, Sanofi
- World Health Organization says Zika virus is no longer international health emergency
- Cancer vaccines market will triple to $7.5B by 2022, report says
- Celgene Invests More in GNS Healthcare For Machine Learning Software
- Almac expands capabilities to meet pediatric formulations demand
Week of November 21, 2016
- Two-thirds of pharmaceutical manufacturing is outsourced, ISR Reports
- Long-lasting pill that releases malaria drug for two weeks a ‘game-changer’
- Chicago to require pharmaceutical rep licenses despite industry objections
- Medidata introduces eConnect partner program
- MIT spin-out invents gastric device which solves problem of daily dosing
Week of November 14, 2016
- New Pharma Rankings On Global Access To Medicine Released
- Pfizer expands humanitarian access to Prevnar 13 vaccine
- AbbVie’s pan-genotypic hep C prospect shines in trials, putting the heat on rival Gilead
- NIH taps a trio of devicemakers for ‘artificial pancreas’ trial
- Physicians use ‘Doctor Google’ daily, but they still rely on traditional info sources, too: study
Week of November 7, 2016
- Merck’s Alzheimer’s drug data fuel hopes for new treatment
- QuintilesIMS announces new biz segments, share repurchase program
- Cempra receives FDA committee support for pneumonia drug
- GSK, Propeller ‘smart inhaler’ gets FDA green light
- Precision BioSciences doubles down on Durham space
Week of October 31, 2016
- Japan’s Takeda Pharmaceutical Seeks to Expand Overseas
- Mylan plans to shutter Meda’s U.S. headquarters, cut 94 jobs
- PPD to support biologics, inhalation products at expanded lab
- Anti-inflammatory drug shows benefit in Alzheimer’s in preclinical trial
- Pfizer Stops Development of Novel PCSK9 Inhibitor, Halts Ongoing Trials
Week of October 24, 2016
- WSJ: A Genetic ‘Chain Saw’ to Target Harmful DNA
- Lexicon gains on positive PhII data in Type 1 diabetes
- Alzheimer’s Drugs Prove Elusive, But Big Pharma Hasn’t Lost Interest
- GSK files for shingles vaccine approval in U.S.
- Merck wins early U.S. approval for Keytruda in untreated lung cancer
- Colorado Therapeutics notches FDA clearance for first product
- WuXi AppTec Unveils Manufacturing Center for Cutting Edge Cell and Gene Therapies
Week of October 17, 2016
- CRISPR Therapeutics Raises $56M In IPO, Half Its Rivals’ Haul
- Merck’s letermovir hits Phase III target
- NC Biotech Center awared more than $1M in loans and awards in Q1
- Sofinnova Raises $650 Million Biotech-focused Venture Fund
- IBM, Quest Diagnostics launch new genomic tumor sequencing service to help advance precision medicine
- Eli Lilly plans $90 million investment to improve health care in poor areas
- Forbes: Is Biopharma Productivity In A Sharp Decline?
Week of October 10, 2016
- Pfizer (PFE) Retracts 5 Articles Authored by Top Cancer Researcher Who Has Since Left the Company
- Allergan (AGN) Looks to Expand Beyond Botox with Oral Migraine Treatments
- Lawsuit Filed Against Theranos Inc. on Behalf of Certain Investors
- Softbank Just Backed This Silicon Valley Biotech Startup
Week of October 3, 2016
- BARDA awards contract to NewLink Genetics for Ebola vaccine development
- Embattled Theranos to Shut Down All Labs and Testing Centers, Cuts About 40% of Workforce
- Cambridge-based Ra Pharmaceuticals files plans for $86M IPO
- Castle Creek Pharmaceuticals Raises $48 Million in Funding from Fidelity Investments
- FDA Grants Breakthrough Therapy Designation For Genentech (RHHBY)’s Actemra (Tocilizumab) In Giant Cell Arteritis, A Form Of Vasculitis
Week of September 26, 2016
- MedPharm Opens U.S. Facility in Research Park Triangle
- Novartis, Amgen chalk up PhIII migraine success to maintain lead over Lilly, Teva
- The end for AbbVie’s bestseller? US FDA approves Amgen’s Humira biosimilar
- Johnson & Johnson hid faulty device concerns during key Xarelto study: BMJ
- FDA full clinical hold throws another wrench into Alcobra’s stuttering R&D machine
Week of September 12, 2016
- Gut Microbiome at birth is predictor of allergies and asthma in later years
- Roche is hopeful new MS drug, Ocrevus, will shake up the market
- Lonza licenses rights to sell synthetic AAVs to gene therapy developers
- Shire launches new marketing campaign for dry eye med Xiidra – the I’s have it
- Avid to construct third plant with two 1,000L single-use bioreactors
Week of September 5, 2016
- Boehringer Ingelheim and Duke Clincial Research Institue expand partnership to study rare disease in real-world setting
- Biogen’s experimental Alzheimer’s drug, Aducanumab, shows progress against plaques
- Flesh eating bacteria vaccine could be around the corner
- Allergan CEO makes price pledge to escape backlash
- GSK hopeful two-drug regimen for HIV will hit the marks
Week of August 28, 2016
- FDA approves a third biosimilar, largest marketed drug to date
- Engineered gut bacteria protects mice against obesity, improves liver function
- New Parkinson’s Diagnostic takes page from Prion Disease testing
- Portola touts new data recently rejected Xarelto, Eliquis antidote
- Cryoport launching logistics study for bioanalytical and clinical trial materials
Week of August 21, 2016
- CRISPR makes it to the Clinic – Promise of Big Payoffs Likely
- Bay area’s AllCells to open tissue collection site in Boston
- GSK urges teens to ‘Take 5’ for MenB in new awareness push
- Melanoma spreading microRNA vesicles a new target for drug therapy
- Cempra Announces European Medicines Agency validates MAA for Solithromycin for treatment of community acquired bacterial pneumonia
Week of August 14, 2016
- Microbial Platforms Set for Rapid Growth
- Up-and-Coming AxoSim hiring Scientists after landing Research Grants to Speed Research
- MIT team seeks to protect privacy, boost access to genetic data using misinformation
- Why CRISPR is an Attractive Approach to Treat Sickle Cell Disease
- Nanotech Drug Delivery Expands Its Range of Applications
Week of August 7, 2016
- Biosimilars are as Good as Brand-Name Drugs, New Study Finds
- Editas partners to bring CRISPR to gene therapy in inherited retinal diseases
- Using Big Data to Battle Cancer
- A Breakthrough in Combating Malaria with odor-baited trap for Mosquitoes
- One protein inhibitor could treat Chagas, Leishmaniasis and Sleeping Sickness
Week of July 31, 2016
- Obesity weighs down the effectiveness of Influenza vaccine
- Study bodes well for Biosimilars but highlights need for more research
- Modified CAR-T prevents ovarian cancer growth in mice
- Researchers have built and artificial neuron
Week of July 24, 2016
- INC Research attains bronze standard
- Microneedle can monitor drugs bloodstream with pain or blood draws
- New Gene Editing tool zeros in on multiple genes simultaneously
- Scientists test nanoparticle drug delivery in dogs with osteosarcoma
Week of July 18, 2016
- Bayer does discovery deal in blood coagulation
- AstraZeneca wants to advance lung cancer drug after hitting PHIII target
- DNA differences predict academic success
- Scientists determine structure of enzyme linked with key cell-signaling protein
- GSK starts RA trial on Apple ResearchKit
Week of July 11, 2016
- Evotec licenses CRISPR gene editing tech
- FDA staffers like Sandoz’ biosimilarity data for copy of Amgen’s Enbrel
- Medtronic wins expanded indication for sinus dilation balloon
- Profusa Wins 7.5M Darpa Biosensor Grant
- Diabetes reversal after bypass surgery linked to changes in gut microorganisms
Week of July 4, 2016
- Customizable RNA Vaccine Successful in Mice
- CRISPR Combats Herpes
- FDA approves Abbott’s Absorb, first completely resorbable heart stent
- Experts Sift Through Tea Leaves for US Biosimilars Market
- Pfizers Growth Strategy: Turning to Smaller M&As
